24小时热门版块排行榜

返回列表

当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

金灶沐

木虫 (著名写手)

应助: 182 (高中生)
金币: 2537.9
散金: 89
红花: 15
沙发: 1
帖子: 1106
在线: 249.6小时
虫号: 1585110
注册: 2012-01-22
性别: GG
专业: 合成药物化学

[交流] 检索各大制药公司进入临床试验药物情况的网站已有23人参与

http://sigma.larvol.com/product.php?e1=604&sourcepg=TZ
包括研发公司，药品代号（名称）、作用机制、临床适应症等。
我也是刚看到，有兴趣的话可以试试，评论一下。

[ Last edited by 金灶沐 on 2014-1-17 at 11:16 ]

回复此楼

» 本帖已获得的红花（最新10朵）

tonchin

» 猜你喜欢

上下几千年，成功之路，离不开老庄孙子

1楼 2014-01-17 11:13:56

已阅回复此楼关注TA 给TA发消息送TA红花 TA的回帖

slimdell

金虫 (初入文坛)

应助: 7 (幼儿园)
金币: 1470.2
红花: 1
帖子: 38
在线: 15.9小时
虫号: 97779
注册: 2005-11-09
专业: 临床药理

★ ★ ★
小木虫: 金币+0.5, 给个红包，谢谢回帖
金灶沐: 回帖置顶 2014-01-20 20:02:59
1949stone: 金币+2, 很满意 2014-02-22 22:25:12

http://www.larvol.com/media/media.html
The Larvol Group Launches Free Online Pharmaceutical Database of Trials and Products - Larvol Sigma
San Francisco, CA – June 26, 2013 - The Larvol Group, LLC announced today that it has officially launched Larvol Sigma, a free pharmaceutical intelligence online resource developed to enable more efficient access to clinicaltrials.gov and EudraCT. With a database containing over 5,000 drugs and more than 150,000 drug trials across all major indications, Larvol Sigma is designed to meet the specific needs of investigators, researchers and industry professionals. "We are excited to share this new product," said company president Bruno Larvol. "We have worked closely with several large pharmaceutical companies to develop a user-friendly pipeline platform with advanced analytics that allows users to focus on specific diseases, companies and mechanisms of action."

To view Larvol Sigma, please visit www.larvolsigma.com. The Larvol Group will be hosting a live Webinar to demonstrate the new platform's capabilities on July 30, 2013 at 9am PDT. Please visit https://www.brighttalk.com/webcast/9739/79119 for more details.

About The Larvol Group, LLC: Founded in 2004, The Larvol Group (www.larvol.com) is a San Francisco-based competitive intelligence company that provides innovative business intelligence services for the pharmaceutical industry. Their customized Market Intelligence Reports track relevant news, clinical trials and developments in the competitive landscape of a given indication. Drawing on the knowledge of over 100 professionals, The Larvol Group has expertise in all major therapeutic areas, including oncology, cardiovascular disease, metabolic diseases, CNS, immunology, women's health and pain management. Their diverse portfolio of clients includes top pharmaceutical companies and small to midsized biotech firms. For more information regarding how The Larvol Group can assist your organization, please contact Natalie Gulley at natalie.gulley@larvol.com or 415.874.3310.